Accordingly, GPER1 genetic mutations promoted a significant decrease in OS (Figure 6C), disease-free survival (DFS) (Figure 6D), disease-specific survival (DSS) (Figure 6E) and progression-free survival (PFS) (Figure 6F) (all p < 0.001) in pan-cancer. Here, GPER1 is linked to cancer.